Friday, March 26, 2021 3:48:58 PM
Item 1.01 Entry into a Material Definitive Agreement.
On March 26, 2021, USA Equities Corp (the “Company”) entered into an Amendment to the Exclusive Distribution Agreement (the “Distribution Agreement”) with MedScience Research Group, Inc., a Florida Corporation (“MedScience”), whereby MedScience granted the Company an exclusive right to distribute its allergy diagnostic and allergen immunotherapy system named AllergiEnd® and related components (the “Products”) for sale to physicians other than allergy specialists. Specifically, to enable the Company to increase its physician network development and marketing efforts and thereby increase revenues to both MedScience and the Company, MedScience agreed to reduce the distribution price to the Company by approximately 20% in return for the Company’s agreement to devote the savings to building out its internal sales force and continue making investments into medical education programs to expand the number of physicians purchasing the products and services provided by MedScience to the Company.
The above description of the Agreement does not purport to be complete and is qualified in its entirety by the full text of such Agreement, which is filed as Exhibit 10.1 hereto and incorporated herein by reference.
Item 8.01 Other Events
The Company has entered into a Recourse Receivables Purchase & Security Agreement with Porter Capital Corporation whereby Porter will make periodic advances to the Company, initially up to $150,000, against designated receivables sold to Porter and secured by substantially all of the Company’s assets. The Company has already used this facility to initiate sales to a number of new physician clients and expects that the facility will help increase its marketing efforts.
https://www.otcmarkets.com/filing/html?id=14829030&guid=3GlpUW6VDUJbO3h
Recent USAQ News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:57:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 01:00:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 12:00:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 01:30:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:00:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 01:00:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 12:00:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 02:33:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 01:22:47 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM